title: Temporal exposure to chondrogenic factors modulates human mesenchymal stem cell chondrogenesis in hydrogels.
abstract: Tissue engineering utilizes scaffolds containing chondrogenic cells to promote cartilage development at a clinically relevant scale, yet there remains a limited understanding of the optimal conditions for inducing differentiation and matrix production. We investigated how cell density and temporal exposure to chondrogenic factors impacted chondrogenesis of human mesenchymal stem cells (hMSCs) encapsulated in poly(ethylene glycol) diacrylate hydrogels. We found maximal proteoglycan and collagen production in constructs seeded between 10 and 25 × 10(6) cells/mL. Matrix deposition was significantly less per cell in constructs seeded at either higher or lower densities, indicating that paracrine communications may remain important despite loss of direct cell-cell contact. In vitro chondrogenesis of hMSCs was first accomplished using pellet cultures and a defined medium containing transforming growth factor (TGF)-β1 and dexamethasone. The differentiation of hMSCs in hydrogels also required initial exposure to TGF-β1, with no chondrogenic matrix produced in its absence. If TGF-β1 was initially included for at least 7 days, its removal impacted collagen production per cell but also lead to an increase in cell number, such that total collagen deposition was equivalent to controls when TGF-β1 was included for at least 3 weeks. Further, proteoglycan content per construct was higher at 6 weeks after removal of TGF-β1 at any time. In contrast to TGF-β1, dexamethasone was not required for chondrogenesis of hMSCs in hydrogels: there was no difference in matrix deposition between hydrogels cultured with or without dexamethasone. Further, without dexamethasone, SOX9 gene expression was higher during early chondrogenesis and there was a significant reduction in collagen I deposition, suggesting that a more hyaline cartilage phenotype is achieved without dexamethasone. Collagen content at 6 weeks was lower if dexamethasone was excluded after the first 7 days, but was equivalent to control if dexamethasone was included for 2 weeks or longer. Proteoglycan deposition was unaffected by dexamethasone exclusion. These results indicate that modulating exposure to TGF-β1 is beneficial for cell survival/proliferation and matrix production from hMSCs in hydrogels, and that not only is dexamethasone dispensable but also its exclusion may be advantageous for forming hyaline cartilage.
authors.affiliation: Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, Oregon, USA.
authors.forename: Amanda N
authors.initials: AN
authors.lastname: Buxton
authors.forename: Chelsea S
authors.initials: CS
authors.lastname: Bahney
authors.forename: Jung U
authors.initials: JU
authors.lastname: Yoo
authors.forename: Brian
authors.initials: B
authors.lastname: Johnstone
mesh_terms: D000328:Adult; D000368:Aged; D018929:Cell Culture Techniques / Q000379:methods; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D020219:Chondrogenesis / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D008875:Middle Aged; D013997:Time Factors; D023822:Tissue Engineering / Q000379:methods*; D055815:Young Adult
chemical_list: D036341:Intercellular Signaling Peptides and Proteins
references.citation: J Cell Physiol. 2009 Apr;219(1):219-26
references.pmid: 19107842
references.citation: Dev Biol. 2008 Apr 1;316(1):62-73
references.pmid: 18295755
references.citation: Histol Histopathol. 2002 Oct;17(4):1239-67
references.pmid: 12371151
references.citation: Arthritis Rheum. 2008 Sep 15;59(9):1207-13
references.pmid: 18759314
references.citation: Arthritis Rheum. 2006 Oct;54(10):3254-66
references.pmid: 17009260
references.citation: Cell Differ. 1975 Jun;4(3):131-7
references.pmid: 167985
references.citation: Science. 1999 Apr 2;284(5411):143-7
references.pmid: 10102814
references.citation: Biochim Biophys Acta. 1986 Sep 4;883(2):173-7
references.pmid: 3091074
references.citation: Curr Top Dev Biol. 2007;79:1-36
references.pmid: 17498545
references.citation: Cell Differ. 1982 Jun;11(4):245-51
references.pmid: 7116459
references.citation: Tissue Eng Part B Rev. 2008 Jun;14(2):149-65
references.pmid: 18498217
references.citation: Exp Cell Res. 1998 Jan 10;238(1):265-72
references.pmid: 9457080
references.citation: Dev Biol. 1982 Nov;94(1):259-64
references.pmid: 6759202
references.citation: Biomaterials. 2001 Mar;22(5):439-44
references.pmid: 11214754
references.citation: Tissue Eng Part A. 2010 Feb;16(2):523-33
references.pmid: 19715387
references.citation: J Cell Physiol. 2010 Jan;222(1):23-32
references.pmid: 19725073
references.citation: J Anat. 1971 Sep;109(Pt 3):411-21
references.pmid: 5153801
references.citation: Nat Biotechnol. 2005 Jan;23(1):47-55
references.pmid: 15637621
references.citation: Endocrinology. 1994 Jan;134(1):277-86
references.pmid: 8275945
references.citation: J Biol Chem. 2003 Oct 17;278(42):41227-36
references.pmid: 12893825
references.citation: J Bone Joint Surg Am. 1998 Dec;80(12):1745-57
references.pmid: 9875932
references.citation: Expert Opin Biol Ther. 2001 Nov;1(6):915-21
references.pmid: 11728225
references.citation: Tissue Eng. 2003 Aug;9(4):679-88
references.pmid: 13678446
references.citation: In Vitro Cell Dev Biol Anim. 2002 Sep;38(8):457-66
references.pmid: 12605540
references.citation: J Orthop Res. 2002 May;20(3):562-74
references.pmid: 12038632
references.citation: J Biol Chem. 2001 Apr 27;276(17):14466-73
references.pmid: 11278290
references.citation: Adv Anat Embryol Cell Biol. 2008;200:1 p following vi, 1-84
references.pmid: 18841755
references.citation: J Bone Joint Surg Am. 2002 May;84(5):793-9
references.pmid: 12004023
references.citation: Bone. 2003 Jul;33(1):1-13
references.pmid: 12919695
references.citation: J Anat. 2000 Nov;197 Pt 4:659-79
references.pmid: 11197539
references.citation: Development. 1997 Jul;124(13):2659-70
references.pmid: 9217007
references.citation: Stem Cells. 2006 Jun;24(6):1487-95
references.pmid: 16469821
references.citation: Injury. 2008 Apr;39 Suppl 1:S58-65
references.pmid: 18313473
references.citation: Z Rheumatol. 1991 Sep-Oct;50(5):304-12
references.pmid: 1776367
references.citation: Tissue Eng. 2007 May;13(5):1025-34
references.pmid: 17417949
references.citation: Osteoarthritis Cartilage. 2006 Feb;14(2):179-89
references.pmid: 16257243
references.citation: Clin Orthop Relat Res. 1994 Apr;(301):271-80
references.pmid: 8156688
references.citation: Tissue Eng. 2007 Oct;13(10):2369-85
references.pmid: 17658993
references.citation: J Cell Biol. 1997 Oct 20;139(2):541-52
references.pmid: 9334355
references.citation: J Bone Joint Surg Am. 2010 Apr;92(4):994-1009
references.pmid: 20360528
references.citation: Tissue Eng. 2003 Dec;9(6):1301-12
references.pmid: 14670117
references.citation: Tissue Eng. 2007 Oct;13(10):2549-60
references.pmid: 17655489
references.citation: Int J Dev Biol. 1999 Jan;43(1):59-67
references.pmid: 10213083
references.citation: J Cell Biol. 1984 Jul;99(1 Pt 1):115-23
references.pmid: 6539780
references.citation: Clin Orthop Relat Res. 2004 Oct;(427 Suppl):S69-77
references.pmid: 15480079